Sigma Planning Corp purchased a new stake in shares of Alteryx Inc (NYSE:AYX) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 3,073 shares of the company’s stock, valued at approximately $258,000.
A number of other hedge funds have also recently added to or reduced their stakes in AYX. BlackRock Inc. lifted its stake in shares of Alteryx by 7.9% in the fourth quarter. BlackRock Inc. now owns 2,439,511 shares of the company’s stock valued at $145,077,000 after buying an additional 177,683 shares during the period. Vanguard Group Inc. lifted its stake in shares of Alteryx by 8.5% in the third quarter. Vanguard Group Inc. now owns 2,432,425 shares of the company’s stock valued at $139,159,000 after buying an additional 191,305 shares during the period. Lord Abbett & CO. LLC lifted its stake in shares of Alteryx by 33.4% in the fourth quarter. Lord Abbett & CO. LLC now owns 871,456 shares of the company’s stock valued at $51,825,000 after buying an additional 218,023 shares during the period. JPMorgan Chase & Co. lifted its stake in shares of Alteryx by 219.2% in the third quarter. JPMorgan Chase & Co. now owns 504,173 shares of the company’s stock valued at $28,844,000 after buying an additional 346,239 shares during the period. Finally, Bank of America Corp DE lifted its stake in shares of Alteryx by 122.0% in the fourth quarter. Bank of America Corp DE now owns 432,306 shares of the company’s stock valued at $25,709,000 after buying an additional 237,603 shares during the period. Institutional investors own 57.94% of the company’s stock.
Several research analysts recently issued reports on the stock. Zacks Investment Research raised shares of Alteryx from a “hold” rating to a “buy” rating and set a $101.00 price target for the company in a research report on Wednesday, May 8th. JMP Securities increased their price target on shares of Alteryx from $84.00 to $96.00 and gave the stock a “market outperform” rating in a research report on Thursday, May 2nd. Needham & Company LLC increased their price target on shares of Alteryx to $108.00 and gave the stock a “buy” rating in a research report on Thursday, May 2nd. Wedbush increased their price target on shares of Alteryx from $76.00 to $93.00 and gave the stock a “neutral” rating in a research report on Thursday, May 2nd. Finally, Bank of America reissued a “buy” rating and issued a $105.00 price target (up previously from $90.00) on shares of Alteryx in a research report on Thursday, May 2nd. Four analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. Alteryx currently has a consensus rating of “Buy” and a consensus target price of $90.25.
NYSE AYX opened at $87.97 on Thursday. The company has a market cap of $5.24 billion, a PE ratio of -439.85, a PEG ratio of 36.09 and a beta of 1.02. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.58 and a quick ratio of 1.58. Alteryx Inc has a 1-year low of $30.71 and a 1-year high of $98.90.
Alteryx (NYSE:AYX) last posted its quarterly earnings data on Wednesday, May 1st. The company reported ($0.02) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.16) by $0.14. The company had revenue of $76.02 million during the quarter, compared to analyst estimates of $71.41 million. Alteryx had a negative net margin of 2.84% and a negative return on equity of 4.90%. The company’s revenue was up 51.0% on a year-over-year basis. During the same quarter last year, the business posted ($0.01) earnings per share. Equities analysts predict that Alteryx Inc will post 0.17 earnings per share for the current year.
In other news, CFO Kevin Rubin sold 109,183 shares of the firm’s stock in a transaction that occurred on Thursday, March 7th. The shares were sold at an average price of $71.73, for a total transaction of $7,831,696.59. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Robert Scott Jones sold 1,598 shares of the firm’s stock in a transaction that occurred on Monday, May 6th. The stock was sold at an average price of $94.63, for a total transaction of $151,218.74. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 248,405 shares of company stock valued at $18,740,671. Company insiders own 19.82% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: This piece of content was first published by Transcript Daily and is owned by of Transcript Daily. If you are accessing this piece of content on another publication, it was illegally stolen and reposted in violation of U.S. & international copyright and trademark law. The correct version of this piece of content can be accessed at https://transcriptdaily.com/2019/05/16/sigma-planning-corp-takes-258000-position-in-alteryx-inc-ayx.html.
Alteryx, Inc operates a self-service data analytics software platform that enables organizations to enhance business outcomes and the productivity of their business analysts, data scientists, and citizen data scientists worldwide. Its software platform includes Alteryx Designer, a data profiling, preparation, blending, and analytics product used to create visual workflows or analytic processes; Alteryx Server, a server-based product for scheduling, sharing, and running analytic processes and applications in a Web-based environment; Alteryx Connect, a collaborative data exploration platform for discovering information assets and sharing recommendations across the enterprise; and Alteryx Promote, an analytics model management product for data scientists and analytics teams to build, manage, monitor, and deploy predictive models into real-time production applications.
Featured Story: How is net asset value different from market price?
Want to see what other hedge funds are holding AYX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Alteryx Inc (NYSE:AYX).
Receive News & Ratings for Alteryx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alteryx and related companies with MarketBeat.com's FREE daily email newsletter.